Tuesday, May 17, 2022
Advertisement

Sweden: Sanolium tops up due 2024 bond by Skr300m

Sanolium, an e-health company providing comprehensive IT solutions to improve healthcare and patient safety, has priced a Skr300m (US$29.9m) tap of its outstanding due...

Switzerland: Swiss Medical Network signs new Sfr250m revolving credit facility

Swiss Medical Network, the second largest private hospital and clinic group in Switzerland and the largest subsidiary of Aevis Victoria, has signed a new...

Funding round-up: Hemispherian, Alan, Engimmune Therapeutics, Xinvento, STENTiT

The Netherlands: STENTiT, an emerging medical device company bringing a novel class of regenerative endovascular implants for the treatment of cardiovascular diseases, has closed...

South Korea: Lunit prepares for KOSDAQ IPO in Q2

Lunit, a Korean Medical AI company, has announced preliminary approval from the Korea Exchange for an IPO on the KOSDAQ market. It plans to...

Financing round-up: Bionter, Loop, HealthBeats, RVAC Medicines, Ordinary Folk

Singapore: Ordinary Folk, a digital health technology startup, has raised US$5m in a pre-Series A funding round led by Monk’s Hill Ventures. Ordinary Folk...

The Netherlands: BioConnection attracts new Gimv-led capital financing

BioConnection, an independent CDMO based in Oss, The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, has completion new capital...

Financing round-up: Rona Therapeutics, Us2.ai, CDR-Life, Phablecare, Prilenia Therapeutics

The Netherlands: Prilenia Therapeutics, a clinical stage biotechnology company focused on developing therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, has raised...

Sweden: Sensidose preparing to IPO on Spotlight Stock Market

Sensidose, a pharmaceutical company that develops and sells individualized dosage of tablets for optimal medical treatment of Parkinson's disease, is preparing to list shares...

Germany: Affimed prices upsized offering of common shares

Nasdaq-listed Affimed, a clinical-stage immuno-oncology company, has priced a public offering of 22.5 million of its common shares at US$4.00 per share to raise...

France: Carmat revives production of Aeson artificial heart with new share issue

Artificial heart designer and developer, Carmat, has raised €40.5m (US$43.9m) from the issuance of new shares at €10 per share. It had originally targeted...